PRJNA263046
RNA seq analysis of patient-derived xenograft from human bladder urothelial carcinoma
We performed RNA-Seq analyses on a primary xenograft tumor line derived from a chemoresistant bladder urothelial carcinoma patient. These xenografts were treated with vehicle as control, gemcitabine-cisplatin (GC) chemotherapy and celecoxib/GC combination therapy as indicated.